Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Intranasal Steroids for the Treatment of Nocturnal Enuresis With Associated Obstructive Sleep Apnea

NCT01861145 is registered in ClinicalTrials.gov with University of Alberta as lead sponsor.

NCT NCT01861145
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01861145 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Intranasal Steroids for the Treatment of Nocturnal Enuresis With Associated Obstructive Sleep Apnea
Lead sponsor
University of Alberta
Phase
Phase 4
Overall status
Withdrawn
Start date
May 31, 2013
Completion date
June 30, 2016
Enrollment
0 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

enuresis, obstructive sleep apnea, sleep disordered breathing